The Cardiac & Vascular Institute First in Florida to Enroll Patients in New Clinical Trial Studying LimFlow Therapy
The Cardiac & Vascular Institute (TCAVI) announced it is the first in Florida to perform a successful procedure in the PROMISE II pivotal study of the LimFlow Percutaneous Deep Vein Arterialization System for the treatment of “no option” Chronic Limb-Threatening Ischemia, a severe... - February 20, 2020
The Cardiac & Vascular Institute Officially Certified as Great Place to Work®
The Cardiac and Vascular Institute was certified as a great workplace by the independent analysts at Great Place to Work®. TCAVI earned this credential based on direct feedback from employees, provided as part of an extensive and anonymous survey about the workplace experience. A summary of... - February 26, 2019
The Cardiac & Vascular Institute and North Florida Regional Medical Center Join Together in a Clinical Trial to Test an Innovative Artificial Intelligence (AI) Device
The Cardiac & Vascular Institute (TCAVI) and North Florida Regional Medical Center (NFRMC) collaborated this week to test an artificial intelligence (AI) device designed to alert clinicians to bleeding episodes during endovascular procedures. According to a press release, the AI device, (named... - January 09, 2019
The Cardiac & Vascular Institute Recognized for Quality Laboratory Services
The Cardiac & Vascular Institute's physicians, laboratory directors and laboratory staff announce to the North Central Florida Community their success in achieving accreditation from COLA, a nonprofit, physician-directed and federal government approved laboratory accrediting organization. - August 29, 2017
The Cardiac & Vascular Institute Research Foundation to Participate in National Institutes of Health TACT2 Research Trial
Second study will focus on benefits of removing toxic metal pollutants in patients with diabetes and a prior heart attack. - December 07, 2016